Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon

Journal of Community Health

Volumn 37, Issue 5, 2012, Pages 917-926

  Wamai, Richard G ^a   Ayissi, Claudine Akono ^a   Oduwo, Geofrey O ^b   Perlman, Stacey ^a   Welty, Edith ^c   Manga, Simon ^c   Ogembo, Javier Gordon ^a,d  

^a NORTHEASTERN UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Cameroon Baptist Convention Health Services (CBCHS)   (Cameroon)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Awareness; Cameroon; Cervical cancer; Human papilloma virus; Parents; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CAMEROON; CHILD PARENT RELATION; CROSS-SECTIONAL STUDY; EARLY DIAGNOSIS; EVALUATION; FEMALE; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PARENT; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SOCIOECONOMICS; UTERINE CERVIX TUMOR; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; CAMEROON; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENT-CHILD RELATIONS; PARENTS; PROGRAM EVALUATION; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84866741055     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-012-9540-5     Document Type: Article

References (49)

1. Allen, J. D., Othus, M. K., Shelton, R. C., Li, Y., Norman, N., Tom, L., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19(9), 2187-2198.
2. Davis, K., Dickman, E. D., Ferris, D., & Dias, J. K. (2004). Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Journal of Lower Genital Tract Disease, 8(3), 188.
3. Lazcano-Ponce, E., Rivera, L., Arillo-Santillán, E., Salmeron, J., Hernández-Avila, M., & Muñoz, N. (2001). Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Archives of Medical Research, 32(3), 243-247.
4. Mays, R. M., Sturm, L. A., & Zimet, G. D. (2004). Parental perspectives on vaccinating children against sexually transmitted infections. Social Science and Medicine, 58(7), 1405-1413.
5. Basu, P., & Mittal, S. (2011). Acceptability of human papillomavirus vaccine among the urban, affluent and educated parents of young girls residing in Kolkata, Eastern india. Journal of Obstetrics and Gynaecology, 37(5), 393-401.
6. Black, L. L., Zimet, G. D., Short, M. B., Sturm, L., & Rosenthal, S. L. (2009). Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine, 27(11), 1668-1673.
7. Francis, S. A., Nelson, J., Liverpool, J., Soogun, S., Mofammere, N., & Thorpe, R. J., Jr. (2010). Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine, 28(50), 8026-8032.
8. McRee, A. L., Reiter, P. L., Gottlieb, S. L., & Brewer, N. T. (2011). Mother-daughter communication about HPV vaccine. Journal of Adolescent Health, 48(3), 314-317.
9. Agosti, J. M., & Goldie, S. J. (2007). introducing HPV vaccine in developing countries-key challenges and issues. The New England Journal of Medicine, 356(19), 1908-1910.
10. Biddlecom, A., Awusabo-Asare, K., & Bankole, A. (2009). Role of parents in adolescent sexual activity and contraceptive use in four African countries. International Perspectives on Sexual and Reproductive Health, 35(2), 72-81.
11. Biddlecom, A., Bankole, A., & Patterson, K. (2006). Vaccine for cervical cancer: Reaching adolescents in sub-Saharan Africa. Lancet, 367(9519), 1299-1300.
12. Kepka, D., Coronado, G. D., Rodriguez, H. P., & Thompson, B. (2011). Evaluation of a radionovela to promote HPV vaccine awareness and knowledge among hispanic parents. Journal of Community Health, 36(6), 957-965.
13. Campos, N. G., Kim, J. J., Castle, P. E., Ortendahl, J. D., O'Shea, M., Diaz, M., et al. (2011). Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. International Journal of Cancer. doi:10.1002/ijc.26269. [Epub ahead of print].
14. Louie, K. S., De Sanjose, S., & Mayaud, P. (2009). Epidemiology and prevention of human papillomavirus and cervical cancer in sub Saharan Africa: A comprehensive review. Tropical Medicine and International Health, 14(10), 1287-1302.
15. Biellik, R., Levin, C., Mugisha, E., LaMontagne, D. S., Bingham, A., Kaipilyawar, S., et al. (2009). Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine, 27(44), 6203-6209.
16. Bingham, A., Drake, J. K., & LaMontagne, D. S. (2009). Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Archives of Pediatrics and Adolescent Medicine, 163(5), 455-461.
17. Mbakop, A., Yomi, J., Yankeum, J., Nkegoum, B., & Mouelle Sone, A. (1997). Cancer localisation in men and women aged over 50 in Cameroon. Bull Cancer, 84(12), 1119-1122.
18. Nghi, N. Q., Lamontagne, D. S., Bingham, A., Rafiq, M., le Mai, T. P., Lien, N. T., et al. (2010). Human papillomavirus vaccine introduction in Vietnam: Formative research findings. Sex Health, 7(3), 262-270.
19. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12-19.
20. Saini, R., Khim, T. P., Rahman, S. A., ismail, M., & Tang, T. H. (2010). High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children. Virology, 7, 131.
21. Cutts, F. T., Franceschi, S., Goldie, S., Castellsague, X., de Sanjose, S., Garnett, G., et al. (2007). Human papillomavirus and HPV vaccines: A review. Bulletin of the World Health Organization, 85(9), 719-726.
22. Farmer, P., Frenk, J., Knaul, F. M., Shulman, L. N., Alleyne, G., Armstrong, L., et al. (2010). Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet, 376(9747), 1186-1193.
23. Franco, E. L., Tsu, V., Herrero, R., Lazcano-Ponce, E., Hildesheim, A., Munoz, N., et al. (2008). integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine, 26(Suppl 11), L88-L95.
24. Burd, E. M. (2003). Human papillomavirus and cervical cancer. Clinical Microbiology Reviews, 16(1), 1-17.
25. Govan, V. A. (2008). A novel vaccine for cervical cancer: Quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil). Therapeutics and Clinical Risk Management, 4(1), 65-70.
26. Bach, P. B. (2010). Gardasil: From bench, to bedside, to blunder. Lancet, 375(9719), 963-964.
27. Anorlu, R. i. (2008). Cervical cancer: The sub-Saharan African perspective. Reproductive Health Matters, 16(32), 41-49.
28. Denny, L., Quinn, M., & Sankaranarayanan, R. (2006). Chapter 8: Screening for cervical cancer in developing countries. Vaccine, 24(Suppl 3), S3/71-S3/77.
29. Munoz, N., Bosch, F. X., Castellsague, X., Diaz, M., de Sanjose, S., Hammouda, D., et al. (2004). Against which human papillomavirus types shall we vaccinate and screen? The International perspective. International Journal of Cancer, 111(2), 278-285.
30. Ponten, J., Adami, H. O., Bergstrom, R., Dillner, J., Friberg, L. G., Gustafsson, L., et al. (1995). Strategies for global control of cervical cancer. International Journal of Cancer, 60(1), 1-26.
31. World Health Organization. (2002). Cervical cancer screening in developing countries: Report of a WHO consultation. Geneva: World Health Organization Press. www.rho.org/files/WHO-CC screening-2002.pdf.
32. Bruni, L., Diaz, M., Castellsague, X., Ferrer, E., Bosch, F. X., & de Sanjose, S. (2010). Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. Journal of infectious Diseases, 202(12), 1789-1799.
33. Tebeu, P. M., Major, A. L., Rapiti, E., Petignat, P., Bouchardy, C., Sando, Z., et al. (2008). The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon. International Journal of Gynecological Cancer, 18(4), 761-765.
34. Winer, R. L., Hughes, J. P., Feng, Q., O'Reilly, S., Kiviat, N. B., Holmes, K. K., et al. (2006). Condom use and the risk of genital human papillomavirus infection in young women [Evaluation StudiesResearch Support, N.I.H., Extramural]. The New England Journal of Medicine, 354(25), 2645-2654.
35. Zondervan, K. T., Carpenter, L. M., Painter, R., & Vessey, M. P. (1996). Oral contraceptives and cervical cancer-further findings from the Oxford Family Planning Association contraceptive study [Multicenter Study]. British Journal of Cancer, 73(10), 1291-1297.
36. Becker-Dreps, S. i., Biddle, A. K., Pettifor, A., Musuamba, G., imbie, D. N., Meshnick, S., et al. (2009). Cost-effectiveness of adding bed net distribution for malaria prevention to antenatal services in Kinshasa, Democratic Republic of the Congo. American Journal of Tropical Medicine and Hygiene, 81(3), 496-502.
37. Gichangi, P., Estambale, B., Bwayo, J., Rogo, K., Ojwang, S., Opiyo, A., et al. (2003). Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. International Journal of Gynecological Cancer, 13(6), 827-833.
38. McFarland, D. M. (2003). Cervical cancer and Pap smear screening in Botswana: Knowledge and perceptions. International Nursing Review, 50(3), 167-175.
39. Mupepi, S. C., Sampselle, C. M., & Johnson, T. R. B. (2011). Knowledge, attitudes, and demographic factors influencing cervical cancer screening behavior of Zimbabwean women. Journal of Women's Health, 20(6), 943-952.
40. Katahoire, R. A., Jitta, J., Kivumbi, G., Murokora, D., Arube, W. J., Siu, G., et al. (2008). An assessment of the readiness for introduction of the HPV vaccine in Uganda. African Journal of Reproductive Health, 12(3), 159-172.
41. Phongsavan, K., Phengsavanh, A., Wahlström, R., & Marions, L. (2010). Women's perception of cervical cancer and its prevention in rural Laos. International Journal of Gynecological Cancer, 20, 5.
42. McCarey, C., Pirek, D., Tebeu, P. M., Boulvain, M., Doh, A. S., & Petignat, P. (2011). Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Women's Health, 11(1), 45.
43. Robyr, R., Nazeer, S., Vassilakos, P., Matute, J. C., Sando, Z., Halle, G., et al. (2002). Feasibility of cytology-based cervical cancer screening in rural Cameroon. Acta Cytologica, 46(6), 1110-1116.
44. Kitchener, H. C., & Symonds, P. (1999). Detection of cervical intraepithelial neoplasia in developing countries. Lancet, 353(9156), 856-857.
45. Doh, A., Nkele, N., Achu, P., Essimbi, F., Essame, O., & Nkegoum, B. (2005). Visual inspection with acetic acid and cytology as screening methods for cervical lesions in Cameroon. International Journal of Gynecology & Obstetrics, 89(2), 167-173.
46. Akmatov, M. K., & Mikolajczyk, R. T. (2011). Timeliness of childhood vaccinations in 31 low and middle-income countries. Journal of Epidemiology and Community Health. doi:10.1136/ jech.2010.124651 [Epub ahead of print].
47. Waters, H. R., Dougherty, L., Tegang, S. P., Nhan, T., Wiysonge, C. S., Kanya, L., et al. (2004). Coverage and costs of childhood immunizations in Cameroon. Bulletin of the World Health Organization, 82(9), 668-675.
48. Saxenian, H. (2007). HPV vaccine adoption in developing countries: Cost and financing issues. International AIDS Vaccine initiative (iAVi). Access number 978-0-9792432-6-4, www.rho. org/files/iAVi-PATH-HPV-financing.pdf.
49. Lefevere, E., Hens, N., De Smet, F., & Van Damme, P. (2011). Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: A Cox regression model. BMC Public Health, 11(1), 470.